Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free THRL Stock Alerts

Target Healthcare REIT (THRL) Competitors

Target Healthcare REIT logo
GBX 105.40 -1.40 (-1.31%)
As of 08:43 AM Eastern
Compare

THRL vs. PHP, AGR, IHR, LABS, and MXF

Should you buy Target Healthcare REIT stock or one of its competitors? MarketBeat compares Target Healthcare REIT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Target Healthcare REIT include Primary Health Properties (PHP), Assura (AGR), Impact Healthcare REIT (IHR), Life Science REIT (LABS), and Medicx Fund (MXF). These companies are all part of the "reit - healthcare facilities" industry.

How does Target Healthcare REIT compare to Primary Health Properties?

Primary Health Properties (LON:PHP) and Target Healthcare REIT (LON:THRL) are both real estate companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Target Healthcare REIT has lower revenue, but higher earnings than Primary Health Properties. Target Healthcare REIT is trading at a lower price-to-earnings ratio than Primary Health Properties, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Primary Health Properties£224M10.76-£8.64M£6.6014.07
Target Healthcare REIT£83.69M7.81£72.07M£12.578.39

Primary Health Properties pays an annual dividend of GBX 7.10 per share and has a dividend yield of 7.6%. Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.6%. Primary Health Properties pays out 107.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend.

Primary Health Properties presently has a consensus target price of GBX 113.40, suggesting a potential upside of 22.13%. Target Healthcare REIT has a consensus target price of GBX 101, suggesting a potential downside of 4.17%. Given Primary Health Properties' stronger consensus rating and higher possible upside, equities analysts clearly believe Primary Health Properties is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Primary Health Properties
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Primary Health Properties has a beta of 0.792, suggesting that its share price is 21% less volatile than the broader market. Comparatively, Target Healthcare REIT has a beta of 0.692098, suggesting that its share price is 31% less volatile than the broader market.

Target Healthcare REIT has a net margin of 104.45% compared to Primary Health Properties' net margin of 45.95%. Target Healthcare REIT's return on equity of 10.73% beat Primary Health Properties' return on equity.

Company Net Margins Return on Equity Return on Assets
Primary Health Properties45.95% 6.03% 3.08%
Target Healthcare REIT 104.45%10.73%3.86%

32.0% of Primary Health Properties shares are owned by institutional investors. Comparatively, 48.8% of Target Healthcare REIT shares are owned by institutional investors. 1.0% of Primary Health Properties shares are owned by insiders. Comparatively, 0.0% of Target Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Primary Health Properties and Primary Health Properties both had 1 articles in the media. Primary Health Properties' average media sentiment score of 1.02 beat Target Healthcare REIT's score of 0.19 indicating that Primary Health Properties is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Primary Health Properties
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Target Healthcare REIT
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Primary Health Properties beats Target Healthcare REIT on 10 of the 17 factors compared between the two stocks.

How does Target Healthcare REIT compare to Assura?

Assura (LON:AGR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

In the previous week, Target Healthcare REIT had 1 more articles in the media than Assura. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Assura. Assura's average media sentiment score of 0.67 beat Target Healthcare REIT's score of 0.19 indicating that Assura is being referred to more favorably in the media.

Company Overall Sentiment
Assura Positive
Target Healthcare REIT Neutral

Assura has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market. Comparatively, Target Healthcare REIT has a beta of 0.692098, meaning that its stock price is 31% less volatile than the broader market.

Target Healthcare REIT has lower revenue, but higher earnings than Assura. Target Healthcare REIT is trading at a lower price-to-earnings ratio than Assura, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Assura£183.80M8.39-£34.15M£0.05895.85
Target Healthcare REIT£83.69M7.81£72.07M£12.578.39

Assura currently has a consensus target price of GBX 60, suggesting a potential upside of 26.37%. Target Healthcare REIT has a consensus target price of GBX 101, suggesting a potential downside of 4.17%. Given Assura's stronger consensus rating and higher probable upside, equities analysts clearly believe Assura is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Assura
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Target Healthcare REIT has a net margin of 104.45% compared to Assura's net margin of 90.32%. Target Healthcare REIT's return on equity of 10.73% beat Assura's return on equity.

Company Net Margins Return on Equity Return on Assets
Assura90.32% 10.66% 2.82%
Target Healthcare REIT 104.45%10.73%3.86%

Assura pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.1%. Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.6%. Assura pays out 63.4% of its earnings in the form of a dividend. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Target Healthcare REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

67.2% of Assura shares are held by institutional investors. Comparatively, 48.8% of Target Healthcare REIT shares are held by institutional investors. 0.9% of Assura shares are held by company insiders. Comparatively, 0.0% of Target Healthcare REIT shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Assura and Target Healthcare REIT tied by winning 9 of the 18 factors compared between the two stocks.

How does Target Healthcare REIT compare to Impact Healthcare REIT?

Impact Healthcare REIT (LON:IHR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk.

Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.6%. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend. Target Healthcare REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

59.5% of Impact Healthcare REIT shares are held by institutional investors. Comparatively, 48.8% of Target Healthcare REIT shares are held by institutional investors. 9.3% of Impact Healthcare REIT shares are held by insiders. Comparatively, 0.0% of Target Healthcare REIT shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Target Healthcare REIT has a consensus target price of GBX 101, suggesting a potential downside of 4.17%. Given Impact Healthcare REIT's higher possible upside, research analysts clearly believe Impact Healthcare REIT is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Impact Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Impact Healthcare REIT has a beta of 0.37, indicating that its stock price is 63% less volatile than the broader market. Comparatively, Target Healthcare REIT has a beta of 0.692098, indicating that its stock price is 31% less volatile than the broader market.

Target Healthcare REIT has a net margin of 104.45% compared to Impact Healthcare REIT's net margin of 88.90%. Target Healthcare REIT's return on equity of 10.73% beat Impact Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Impact Healthcare REIT88.90% 9.90% 4.30%
Target Healthcare REIT 104.45%10.73%3.86%

Target Healthcare REIT has higher revenue and earnings than Impact Healthcare REIT. Impact Healthcare REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Impact Healthcare REIT£53.51M0.00£47.58M£0.11N/A
Target Healthcare REIT£83.69M7.81£72.07M£12.578.39

In the previous week, Target Healthcare REIT had 1 more articles in the media than Impact Healthcare REIT. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Impact Healthcare REIT. Target Healthcare REIT's average media sentiment score of 0.19 beat Impact Healthcare REIT's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the news media.

Company Overall Sentiment
Impact Healthcare REIT Neutral
Target Healthcare REIT Neutral

Summary

Target Healthcare REIT beats Impact Healthcare REIT on 11 of the 16 factors compared between the two stocks.

How does Target Healthcare REIT compare to Life Science REIT?

Target Healthcare REIT (LON:THRL) and Life Science REIT (LON:LABS) are both small-cap real estate companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

Target Healthcare REIT has a beta of 0.692098, suggesting that its share price is 31% less volatile than the broader market. Comparatively, Life Science REIT has a beta of 0.08, suggesting that its share price is 92% less volatile than the broader market.

Target Healthcare REIT has a net margin of 104.45% compared to Life Science REIT's net margin of -145.80%. Target Healthcare REIT's return on equity of 10.73% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.45% 10.73% 3.86%
Life Science REIT -145.80%-12.37%1.25%

48.8% of Target Healthcare REIT shares are held by institutional investors. Comparatively, 25.5% of Life Science REIT shares are held by institutional investors. 0.0% of Target Healthcare REIT shares are held by company insiders. Comparatively, 0.0% of Life Science REIT shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Target Healthcare REIT presently has a consensus target price of GBX 101, indicating a potential downside of 4.17%. Given Target Healthcare REIT's stronger consensus rating and higher possible upside, equities analysts clearly believe Target Healthcare REIT is more favorable than Life Science REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Life Science REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.6%. Life Science REIT pays an annual dividend of GBX 1 per share and has a dividend yield of 2.3%. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend. Life Science REIT pays out -11.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Target Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£83.69M7.81£72.07M£12.578.39
Life Science REIT-£22.01M-6.85-£40.62M-£8.80N/A

In the previous week, Target Healthcare REIT had 1 more articles in the media than Life Science REIT. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Life Science REIT. Target Healthcare REIT's average media sentiment score of 0.19 beat Life Science REIT's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Overall Sentiment
Target Healthcare REIT Neutral
Life Science REIT Neutral

Summary

Target Healthcare REIT beats Life Science REIT on 16 of the 17 factors compared between the two stocks.

How does Target Healthcare REIT compare to Medicx Fund?

Target Healthcare REIT (LON:THRL) and Medicx Fund (LON:MXF) are both real estate companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Target Healthcare REIT has a net margin of 104.45% compared to Medicx Fund's net margin of 0.00%. Target Healthcare REIT's return on equity of 10.73% beat Medicx Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.45% 10.73% 3.86%
Medicx Fund N/A N/A N/A

48.8% of Target Healthcare REIT shares are owned by institutional investors. 0.0% of Target Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Target Healthcare REIT presently has a consensus target price of GBX 101, indicating a potential downside of 4.17%. Given Medicx Fund's higher probable upside, analysts clearly believe Medicx Fund is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Medicx Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Target Healthcare REIT has higher revenue and earnings than Medicx Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£83.69M7.81£72.07M£12.578.39
Medicx FundN/AN/AN/AN/AN/A

In the previous week, Target Healthcare REIT had 1 more articles in the media than Medicx Fund. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Medicx Fund. Target Healthcare REIT's average media sentiment score of 0.19 beat Medicx Fund's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Overall Sentiment
Target Healthcare REIT Neutral
Medicx Fund Neutral

Summary

Target Healthcare REIT beats Medicx Fund on 9 of the 10 factors compared between the two stocks.

Get Target Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THRL vs. The Competition

Export
MetricTarget Healthcare REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£653.73M£2.15B£1.96B£2.79B
Dividend Yield5.66%7.12%6.93%6.09%
P/E Ratio8.39114.7927.20366.06
Price / Sales7.81541.19843.0188,434.23
Price / Cash14.3749.2268.0627.89
Price / Book0.951.551.307.66
Net Income£72.07M-£74.43M-£124.57M£5.89B
7 Day Performance-3.12%-1.22%-0.66%0.68%
1 Month Performance-1.31%0.48%-0.22%2.66%
1 Year Performance6.46%13.55%3.91%87.65%

Target Healthcare REIT Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THRL
Target Healthcare REIT
1.7009 of 5 stars		GBX 105.40
-1.3%		GBX 101
-4.2%		+7.2%£653.73M£83.69M8.39N/A
PHP
Primary Health Properties
4.1328 of 5 stars		GBX 93.90
-0.2%		GBX 113.40
+20.8%		-6.5%£2.44B£224M14.2358
AGR
Assura
2.4497 of 5 stars		GBX 47.48
+0.4%		GBX 60
+26.4%		-2.5%£1.54B£183.80M895.8584
IHR
Impact Healthcare REIT
N/AN/AN/AN/A£361.75M£53.51M793.64N/A
LABS
Life Science REIT
N/AGBX 43.10
flat		N/AN/A£150.85M-£22.01MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:THRL) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
The US sanctioned itself out of world reserve status…
Russia and Iran are both bypassing the US petrodollar - settling oil trades in alternative currencies while ce...
Golden Portfolio | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Secret behind near perfectly timed stock trades…?
After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he ...
Traders Agency | Sponsoredtc pixel
Is this AI lab Elon’s SpaceX lifeline?
Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...
Chaikin Analytics | Sponsoredtc pixel